Medicare Enrolled
Dr. Marays Veliz, MD
Hematology · Leesburg, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Veliz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Veliz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Veliz
Dr. Marays Veliz is a hematology specialist in Leesburg, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Veliz performed 104,325 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Veliz received a total of $10,753 from 68 pharmaceutical and/or device companies across 608 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Veliz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 43% volume in FL
$10,753 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗104,325
Medicare services
Top 43% in FL for hematology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
45,900 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
17,940 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
9,400 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 7,560 | $18 | $51 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
7,500 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 4,680 | $1 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,953 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,878 | $8 | $9 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,686 | $0 | $3 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
863 | $10 | $69 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
719 | $67 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 620 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
546 | $93 | $339 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
391 | $1 | $6 |
| Anti-nausea injection (ondansetron/Zofran) | 372 | $0 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
285 | $97 | $378 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
275 | $12 | $61 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
230 | $47 | $189 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
197 | $54 | $206 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
138 | $21 | $79 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
100 | $136 | $556 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
100 | $1 | $3 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
85 | $15 | $56 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
80 | $22 | $84 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $63 | $197 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
77 | $28 | $156 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
75 | $10 | $42 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
68 | $17 | $59 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
60 | $49 | $178 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
60 | $3 | $11 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
54 | $4 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $86 | $298 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
45 | $103 | $377 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $7 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
36 | $94 | $285 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $135 | $474 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
30 | $1 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
29 | $2 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $126 | $453 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
24 | $5 | $20 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
21 | $25 | $156 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
15 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 15 | $173 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
44.8% high complexity
49.7% medium
5.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,753
Total received (2018-2024)
Avg $1,536/year across 7 years
Top 41% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
608
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,679
2023
$1,471
2022
$1,561
2021
$1,682
2020
$1,229
2019
$1,880
2018
$1,252
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$264
Celgene Corporation
$202
BeiGene USA, Inc.
$133
AstraZeneca Pharmaceuticals LP
$125
Merck Sharp & Dohme LLC
$113
GENZYME CORPORATION
$99
Tempus AI, Inc
$70
ABBVIE INC.
$65
PFIZER INC.
$61
Eisai Inc.
$60
Regeneron Healthcare Solutions, Inc.
$58
Takeda Pharmaceuticals U.S.A., Inc.
$54
Gilead Sciences, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$43
Kite Pharma, Inc.
$43
Incyte Corporation
$26
GlaxoSmithKline, LLC.
$26
Janssen Biotech, Inc.
$25
Agios Pharmaceuticals, Inc.
$24
JAZZ PHARMACEUTICALS INC.
$23
Pharmacosmos Therapeutics Inc.
$21
EMD Serono, Inc.
$20
TerSera Therapeutics LLC
$19
Astellas Pharma US Inc
$19
Lilly USA, LLC
$18
Alexion Pharmaceuticals, Inc.
$17
Top 3 companies account for 35.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,038
Janssen Biotech, Inc.
$939
E.R. Squibb & Sons, L.L.C.
$685
Celgene Corporation
$561
Seagen Inc.
$523
Genentech USA, Inc.
$444
Amgen Inc.
$422
AstraZeneca Pharmaceuticals LP
$416
Incyte Corporation
$374
PFIZER INC.
$343
GENZYME CORPORATION
$339
Merck Sharp & Dohme LLC
$296
Eisai Inc.
$267
Merck Sharp & Dohme Corporation
$257
EMD Serono, Inc.
$228
BeiGene USA, Inc.
$216
Astellas Pharma US Inc
$198
Kite Pharma, Inc.
$183
Bayer HealthCare Pharmaceuticals Inc.
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Pharmacyclics LLC, An AbbVie Company
$150
Daiichi Sankyo Inc.
$148
Foundation Medicine, Inc.
$143
Lilly USA, LLC
$141
ABBVIE INC.
$140
Gilead Sciences, Inc.
$128
Takeda Pharmaceuticals U.S.A., Inc.
$120
GlaxoSmithKline, LLC.
$114
MorphoSys, US Inc.
$99
JAZZ PHARMACEUTICALS INC.
$98
Regeneron Healthcare Solutions, Inc.
$78
EISAI INC.
$74
Alexion Pharmaceuticals, Inc.
$71
Octapharma USA, Inc.
$71
Tempus AI, Inc
$70
Agios Pharmaceuticals, Inc.
$69
Rigel Pharmaceuticals, Inc.
$62
G1 Therapeutics, Inc.
$61
Stemline Therapeutics Inc.
$57
TerSera Therapeutics LLC
$54
ARRAY BIOPHARMA INC
$52
Ipsen Biopharmaceuticals, Inc
$47
Karyopharm Therapeutics Inc.
$46
Clovis Oncology, Inc.
$42
Pharmacosmos Therapeutics Inc.
$41
CTI BioPharma Corp.
$41
TESARO, Inc.
$39
Dova Pharmaceuticals
$38
Seattle Genetics, Inc.
$36
Pharmacyclics LLC, an AbbVie Company
$36
Teva Pharmaceuticals USA, Inc.
$36
Array BioPharma Inc.
$31
AbbVie Inc.
$25
Aurobindo Pharma USA, Inc.
$24
Telix Pharmaceuticals
$23
Apellis Pharmaceuticals, Inc.
$22
EUSA Pharma (US) LLC
$20
Exelixis Inc.
$19
Global Blood Therapeutics, Inc.
$17
Taiho Oncology, Inc.
$17
ADC Therapeutics America, Inc.
$16
AVEO Pharmaceuticals, Inc.
$15
Epizyme, Inc.,
$15
Mirati Therapeutics, Inc.
$14
Heron Therapeutics, Inc.
$13
Dendreon Pharmaceuticals LLC
$13
Grifols USA, LLC
$12
AbbVie, Inc.
$11
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · AUGTYRO · Abraxane · Alecensa · Aliqopa · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · Creon · DARZALEX · Doptelet · ELITEK · ELREXFIO · ENHERTU · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LOKELMA · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Neulasta · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolastin-C Liquid · REBLOZYL · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · Sustol · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
8
County median income
$69,956
Nearest hospital to ZIP centroid (approximate)
UF HEALTH LEESBURG HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Veliz is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Veliz experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Veliz performed 45,900 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Veliz receive payments from pharmaceutical companies?
Yes. Dr. Veliz received a total of $10,753 from 68 companies across 608 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Veliz's costs compare to other hematologists in Leesburg?
Dr. Veliz's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Veliz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Leesburg
Browse hematologists in Leesburg ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology